Myeloproliferative neoplasia: a review of clinical criteria and treatment

Keyphrases

• Clinical Treatment 100%
• Myeloproliferative Neoplasms 100%
• Clinical Criteria 100%
• Clinical Features 50%
• Working Mechanism 50%
• Bone Marrow Cells 50%
• Essential Thrombocythemia 50%
• Polycythemia Vera 50%
• Stem Cell Deficiency 50%
• Megakaryocytic 50%
• Primary Myelofibrosis 50%
• Erythroid 50%
• JAK2 mutation 50%
• Philadelphia Chromosome-negative 50%
• Histopathological Features 50%
• Internal Medicine Physicians 50%

Medicine and Dentistry

• Neoplasm 100%
• Cell Line 100%
• Internal Medicine 50%
• Essential Thrombocythaemia 50%
• Polycythemia vera 50%
• Disease 50%
• Myeloid metaplasia 50%
• Janus Kinase 50%
• Philadelphia 1 Chromosome 50%
• Hematopoietic Cell 50%

INIS

• patients 100%
• reviews 100%
• symptoms 33%
• genes 33%
• mutations 33%
• stem cells 33%
• proliferation 33%
• bone marrow 33%
• internal medicine 33%
• polycythemia 33%
• philadelphia chromosome 33%